Shares jumped over 8% after the company reported an 86% YoY surge in Q3FY26 net profit, driven by strong revenue growth, ...

Sai Life Sciences rose 5.29% to Rs 854.10 after the company reported a strong operational and financial performance for the quarter ended 31 December 2025.

Mabtech, a global life science tools company specializing in advanced immunoassays, and Sai Life Sciences, a leading integrated Contract Research, Development, and Manufacturing Organization (CRDMO), ...

HYDERABAD, India, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Sai Life Sciences Limited (BSE: 544306 I NSE: SAILIFE), an innovator focused Contract Research, Development, and Manufacturing Organization (CRDMO), ...

HYDERABAD, India, Aug. 21, 2023 (GLOBE NEWSWIRE) -- Sai Life Sciences, a global Contract Research, Development & Manufacturing Organization (CRO-CDMO), entered its Silver Jubilee year with aplomb, ...

Sai Life Sciences is looking to expand its Research & Development (R&D) capabilities as it reels at the equity markets. The ...

HYDERABAD, India, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Sai Life Sciences Limited (BSE: 544306 | NSE: SAILIFE), one of India’s fastest-growing Contract Research, Development, and Manufacturing ...

Sai Life Sciences’ Veterinary APIs Unit in Bidar, India. The new facility is designed to meet the highest standards of safety, sustainability, and regulatory compliance, ensuring the production of ...

Sai Life Sciences IPO allotment date and time, Sai Life Sciences IPO allotment status check online: Sai Life Sciences's initial public offer (IPO) opened for subscription on December 11 and closed on ...

HYDERABAD, India, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Sai Life Sciences, a leading global Contract Research, Development & Manufacturing Organization (CRO/ CDMO), released its Sustainability Report 2022 ...

Mabtech, a global life science tools company specializing in advanced immunoassays, and Sai Life Sciences, a leading integrated Contract Research ...